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GAPDH: glyceraldehyde-3-phosphate dehydrogenase 
HPDLC: human periodontal ligament cells 
HRP: horseradish peroxidase 
IL: interleukin 
IκB: inhibitor of kappa B 
ISHC: IL-1β-stimulated HPDLC 
NF-κB: nuclear factor κB 
PBS: phosphate-buffered saline 
RANKL: receptor activator of nuclear factor κB ligand 
TNF: tumor necrosis factor 
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Abstract 
Alkannin, which is found in Alkanna tinctoria, a member of the borage family, is used as a 
food coloring. Alkannin has recently been reported to have certain biological functions, such 
as anti-microbial and anti-oxidant effects. It is known that CC chemokine receptor (CCR) 
5-positive leukocytes contribute to alveolar bone resorption in periodontal lesions. The aim of 
this study was to examine whether alkannin inhibits the production of CC chemokine ligand 
(CCL) 3 and CCL5, which are CCR5 ligands, in human periodontal ligament cells (HPDLC). 
Interleukin (IL)-1β  induced CCL3 and CCL5 production in HPDLC. Alkannin inhibited 
IL-1β-mediated CCL3 and CCL5 production in HPDLC in a dose-dependent manner. 
Moreover, we revealed that alkannin suppressed inhibitor of kappa B-α degradation in 
IL-1β-stimulated HPDLC. In addition, a nuclear factor (NF)-κB inhibitor significantly 
inhibited CCL3 and CCL5 production in IL-1β-stimulated HPDLC. These results 
demonstrate that alkannin inhibits CCR5 ligand production in IL-1β-stimulated HPDLC by 
attenuating the NF-κB signaling pathway. 
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1. Introduction 
Periodontal disease is characterized by gingival inflammation, inflammatory cell infiltration, 
and alveolar bone resorption, which are induced in response to the bacteria present in 
biofilms. Previous studies have revealed that the immune responses seen in periodontal 
lesions are involved in the initiation and progression of periodontitis (Teng et al., 2003; 
Taubman et al., 2005). Recently, it has been found that CC chemokine receptor (CCR) 5+ 
leukocytes contribute to bone destruction in periodontal lesions (Ferreira et al., 2011). 
Ferreira et al. (2011) reported that CCR5+CD4+ cells express high levels of receptor 
activator of nuclear factor κB ligand (RANKL). In addition, the CCR5+F4/80 leukocytes that 
they detected in periodontal lesions were demonstrated to be active macrophages because 
they expressed interleukin (IL)-1β and tumor necrosis factor α. Therefore, the CCR5+ 
leukocytes found in tissues affected by periodontal disease are pro-osteoclastic or 
osteoclastogenic cell subsets (Ferreira et al., 2011). They also reported that the absence of 
CCR5 in mice reduced alveolar bone resorption and inflammatory cell accumulation in an 
experimental periodontal disease model (Ferreira et al., 2011). Therefore, CCR5+ leukocytes 
might be a target of periodontal disease treatment.  
CC chemokine ligands (CCL) 3, 4, and 5 are ligands of CCR5 (Mueller et al., 2004). They 
are involved in the migration and accumulation of CCR5+ leukocytes in inflammatory 
lesions. There have been a number of reports about the expression of CCR5 ligands in human 
periodontal lesions. Thunell et al. (2010) reported that CCL3 and CCL5 were detected in 
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gingival crevicular fluid samples obtained from chronic periodontitis patients, and the initial 
treatment reduced the levels of CCL3 and CCL5 in gingival crevicular fluid. In an 
immunohistochemical study, Gemmell et al. (2000) revealed that CCL3+ cells and CCL5+ 
cells are present in human periodontal lesions. Therefore, CCL3 and CCL5 seem to be 
involved in the migration of CCR5+ cells in periodontal lesions. Recently, Nebel et al. (2010) 
reported that human periodontal ligament cells (HPDLC) that had been stimulated with 
lipopolysaccharide (LPS) from Escherichia coli produced CCL3 and CCL5. However, it is 
unclear if other molecules induce CCR5 ligand production in HPDLC. 
Alkannin is a natural plant dye that is found in extracts of Alkanna tinctoria, a member of the 
borage family that grows in the south of France. Alkannin is used as a food coloring. It is 
known that alkannin has biological effects, such as anti-microbial (Rajbhandari et al., 2007) 
and anti-cancer effects (Deng et al., 2010). However, the effects of alkannin on chemokine 
production are uncertain.  
Nuclear factor κB (NF-κB) plays an important role in inflammatory responses, such as 
cytokine and chemokine production. We previously reported that IL-1β  activates the NF-κB 
pathway in HPDLC (Shindo et al., 2014), and the NF-κB pathway is positively associated 
with CCL20 and IL-6 production. However, it is unclear whether the NF-κB pathway is 
involved in CCL3 or CCL5 production in IL-1β-stimulated HPDLC (ISHC). Moreover, we 
do not know if alkannin suppresses NF-κB activation in ISHC. 
In the present study, we examined the effects of alkannin on CCR5 ligand production in 
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ISHC. In addition, we investigated whether alkannin modulates the NF-κB pathway in order 
to explore which signal transduction pathways it affects.  
2. Materials and Methods 
2.1. Cell culture 
HPDLC were obtained from Lonza Japan (Tokyo, Japan) and grown in Dulbecco’s modified 
Eagle’s medium (Sigma, St. Louis, MO, USA) supplemented with 10% fetal bovine serum 
(Gibco, Grand Island, NY, USA) and antibiotics (penicillin G: 100 units/ml, streptomycin: 
100 µg/ml) at 37°C in humidified air containing 5% CO2. The cells were used between 
passage numbers 5 and 10. 
2.2. CCL3 and CCL5 production in HPDLC 
HPDLC were seeded at a density of 0.5 × 104 cells/cm2 in a 24-well cell culture plate. After 
they had reached confluence, the HPDLC were stimulated with recombinant human 
IL-1β (Peprotech, Rocky Hill, NJ, USA) for 24 hours. The supernatants of the HPDLC 
cultures were collected, and the CCL3 and CCL5 concentrations of the culture supernatants 
were measured in triplicate with ELISA. DuoSet ELISA kits (R&D systems, Minneapolis, 
MN, USA) were used for each assay. All assays were performed according to the 
manufacturer’s instructions, and chemokine levels were determined using the standard curve 
prepared for each assay. In selected experiments, the HPDLC were cultured for 1 hour in the 
presence or absence of alkannin (0.25, 0.5, 1, or 2 µM; Nagara Science Co., Ltd., Gifu, 
Japan) or SC514 (a selective NF-κB inhibitor, 10 µM; Santa Cruz Biotechnology, Inc., Dallas, 
 7 
TX, USA) prior to their incubation with IL-1β. 
2.3. Western blot analysis 
Western blot analysis was performed to examine the IL-1β-induced phosphorylation or 
degradation of signal transduction molecules. HPDLC were seeded at a density of 0.5 × 104 
cells/cm2 in a 12-well cell culture plate. After reaching confluence, the HPDLC were 
subjected (or not) to alkannin (0.5 µM, 1 µM) pretreatment for 1 hour, stimulated with IL-1β 
(1 ng/ml), washed once with ice-cold PBS, and then incubated on ice for 30 min with cell 
lysis buffer (Cell Signaling Technology, Danvers, MA, USA) supplemented with protease 
inhibitor cocktail (Sigma). After the removal of debris by centrifugation, the protein 
concentrations of the lysates were quantified with the Bradford protein assay using IgG as a 
standard. A 20-µg protein sample was loaded onto a 4-20% sodium dodecyl sulfate 
polyacrylamide gel electrophoresis gel, before being electrotransferred to a polyvinylidene 
difluoride membrane. The phosphorylation of NF-κB p65 and the degradation of inhibitor of 
kappa B (IκB)-α were assessed using phospho-NF-κB p65 rabbit monoclonal antibody (Cell 
Signaling Technology), NF-κB p65 rabbit monoclonal antibody (Cell Signaling Technology), 
IκB-α mouse monoclonal antibody (Cell Signaling Technology), or GAPDH rabbit 
monoclonal antibody (Cell Signaling Technology) according to the manufacturer’s 
instructions. The resultant protein bands were visualized via incubation with the horseradish 
peroxidase-conjugated secondary antibody (Sigma), followed by detection using the ECL 
prime Western blotting detection system (GE Healthcare, Uppsala, Sweden). The 
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quantitation of the chemiluminescent signals was performed using ImageJ (version 1.44). 
2.4. Statistical analysis 
Statistical significance was analyzed using one-way ANOVA. P-values of <0.05 were 
considered to be significant in the analyses shown in Figs. 1, 2, and 4. 
3. Results 
3.1. Effects of IL-1β on CCR5 ligand production in HPDLC  
We first examined whether IL-1β induces CCR5 ligand production in HPDLC. Figure 1 
shows that CCL3 and CCL5 were produced in ISHC in an IL-1β dose-dependent manner.  
3.2. Effects of alkannin on CCL3 and CCL5 production in ISHC 
Next, we examined whether alkannin inhibited CCL3 or CCL5 production in ISHC because 
we wanted to determine the anti-inflammatory effects of alkannin. Figure 2 shows that 0.5 
µM of alkannin significantly inhibited CCL3 and CCL5 production in ISHC. The inhibitory 
effects of alkannin were dose-dependent.  
3.3. Effects of alkannin on NF-κB p65 phosphorylation and IκB-α degradation in ISHC 
Moreover, we examined the effects of alkannin on the NF-κB pathway because it is known 
that IL-1β activates the NF-κB pathway in HPDLC (Murayama et al., 2011; Shindo et al., 
2014), and the NF-κB pathway is involved in the production of various chemokines (Smith et 
al., 1997; Roebuck et al., 1999). Figure 3 shows that alkannin inhibited IκB-α degradation, 
but did not affect NF-κB p65 phosphorylation, in ISHC.  
3.4. Effects of an NF-κB inhibitor on CCL3 and CCL5 production in ISHC 
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Finally, we examined whether the NF-κB pathway is involved in CCL3 or CCL5 production 
in ISHC using SC514, an NF-κB inhibitor. Figure 4 shows that SC514 significantly inhibited 
CCL3 and CCL5 production. These results demonstrated that the NF-κB pathway is essential 
for CCL3 and CCL5 production in ISHC. 
4. Discussion 
We demonstrated that IL-1β induced CCL3 and CCL5 production in HPDLC. A previous 
study showed that HPDLC produced CCL3 and CCL5 after LPS stimulation (Nebel et al., 
2010). Therefore, HPDLC might enhance CCR5+ leukocyte accumulation in order to 
increase CCL3 and CCL5 production. Moreover, it is reported that LPS upregulated the 
release of CCL3 or CCL5 from human epithelial cells (Ryu et al., 2007; Basso et al., 2015) 
and human gingival fibroblasts (Ryu et al., 2007; Morandini et al., 2010). Furthermore, Ryu 
et al. (2007) stated that IL-1β induced CCL3 production in human gingival epithelial cells. 
The findings of our and previous studies suggested that the release of CCL3 and CCL5 from 
LPS- or IL-1β-stimulated resident periodontal cells might be involved in CCR5+ leukocyte 
accumulation in periodontal lesions. Moreover, we found that alkannin inhibited IL-6, IL-8, 
and CCL20 production in ISHC (data not shown). So, we consider that alkannin could relieve 
inflammatory reactions in periodontal lesions by decreasing inflammatory cytokine 
expression.  
There have been a few reports about the anti-inflammatory effects of alkannin. Wang et al. 
(2015) reported that alkannin suppressed IL-6, IL-12, IL-23, and IL-1β production in 
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dendritic cells. They also showed that alkannin treatment reduced IL-23 expression in skin 
lesions in a psoriasis mouse model (Wang et al., 2015). We found that alkannin inhibited 
CCL3 and CCL5 production in HPDLC. Next, we should examine whether alkannin is able 
to suppress CCL3 and CCL5 expression and alveolar bone resorption in the lesions of a 
periodontal disease mouse model. 
In this study, we demonstrated that alkannin inhibited IκB-α degradation in HPDLC. IκB-α 
degradation is an important event in the activation of the NF-κB pathway because IκB-α 
binds to NF-κB and inhibits the translocation of NF-κB into the nucleus. We showed that 1 
µM alkannin markedly inhibited IκB-α degradation in ISHC. On the other hand, 0.5 µM 
alkannin did not inhibit IκB-α degradation in ISHC even though CCL3 and CCL5 production 
were decreased. We consider that low doses of alkannin might also modulate signal 
transduction pathways other than NF-κB. In addition, we found that IκB-α degradation was 
strongly inhibited at 15 minutes after the addition of 1 µM alkannin, and the results obtained 
at 30 and 60 minutes indicated that the inhibitory effects of alkannin on IκB-α degradation 
decreased gradually over time. We consider that the molecules released from ISHC might 
modulate the effects of alkannin. Further studies are necessary to address this issue. A 
previous study demonstrated the effects of alkannin on NF-κB pathway activation. Yoshihisa 
et al. (2012) reported that alkannin pretreatment suppressed IκB-α degradation and NF-κB 
nuclear translocation in human keratinocytes after ultraviolet B (UVB) irradiation. They used 
1 µM alkannin in their experiment, as did we. They also reported that alkannin treatment 
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reduced the mRNA expression levels of IL-1β, IL-6, and IL-8, which are regulated by NF-κB, 
in human keratinocytes after UVB irradiation (Yoshihisa et al., 2012). Their study and our 
study indicate that alkannin is able to suppress the activation of the NF-κB pathway in some 
types of cells and reduce inflammatory cytokine production in inflammatory lesions.  
5. Conclusions 
In conclusion, our results indicate that IL-1β induces CCL3 and CCL5 production in HPDLC, 
and alkannin suppresses CCL3 and CCL5 production in ISHC. However, we do not know 
whether alkannin is able to suppress CCR5 ligand production in other resident periodontal 
cells, such as gingival fibroblasts and gingival epithelial cells. Moreover, it is uncertain if 
alkannin is able to inhibit CCR5+ leukocyte migration and accumulation in periodontal 
lesions. We should conduct further investigations to address these questions.  
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Figure legends 
Fig. 1. Effects of IL-1β on CCL3 and CCL5 production in HPDLC 
HPDLC were stimulated with IL-1β (0.1, 1, or 10 ng/ml), and the supernatants were collected 
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after 24 hours. The levels of CCL3 (A) and CCL5 (B) in the supernatants were measured 
using ELISA. The results are shown as the mean and standard deviation (SD) of one 
representative experiment performed in triplicate. The error bars show SD values. * = P<0.05, 
significantly different from the non-stimulated HPDLC 
Fig. 2. Effects of alkannin on CCL3 and CCL5 production in ISHC 
  HPDLC were pretreated with alkannin (0.25, 0.5, 1, or 2 µΜ) for 1 hour and then were 
stimulated with IL-1β (1 ng/ml). The supernatants were collected after 24 hours. The levels 
of CCL3 (A) and CCL5 (B) in the supernatants were measured using ELISA. The results are 
shown as the mean and SD of one representative experiment performed in triplicate. The 
error bars show SD values. * = P<0.05, significantly different from the IL-1β-stimulated 
HPDLC that were not treated with alkannin 
Fig. 3. Effects of alkannin on IL-1β-induced NF-κB p65 phosphorylation and IκB-α 
degradation 
 The cultured cells were pretreated with alkannin (0.5 or 1 µM) for 60 min and then 
stimulated with IL-1β (1 ng/ml) for 15, 30, or 60 min. The cells were lysed in lysis buffer 
containing protease inhibitors, and the phosphorylation of NF-κB p65 and degradation of 
IκB-α were assessed using Western blot analysis. A representative Western blot showing the 
phospho-NF-κB p65, total-NF-κB p65, total-IκB-α, and GAPDH levels detected in HPDLC 
in three independent experiments. 
Fig. 4. Effects of an NF-κB inhibitor on CCL3 and CCL5 production in ISHC 
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  HPDLC were pretreated with SC514 (10 µΜ) for 1 hour, before being stimulated with 
IL-1β (1 ng/ml), and the supernatants were collected after 24 hours. The levels of CCL3 (A) 
and CCL5 (B) in the supernatants were measured using ELISA. The results are shown as the 
mean and SD of one representative experiment performed in triplicate. The error bars show 
SD values. * = P<0.05, significantly different from the ISHC that were not subjected to 
SC514 treatment 
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